Logo image of ALSAF.PA

SAFE ORTHOPAEDICS SA (ALSAF.PA) Stock Price, Forecast & Analysis

Europe - Euronext Paris - EPA:ALSAF - FR001400ZU25 - Common Stock

1.09 EUR
-0.01 (-0.91%)
Last: 1/14/2026, 7:00:00 PM

ALSAF.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap196.20K
Revenue(TTM)4.96M
Net Income(TTM)-1.77B
Shares180.00K
Float0
52 Week High2.6
52 Week Low0
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-229246.54
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2015-02-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
ALSAF.PA short term performance overview.The bars show the price performance of ALSAF.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10K 20K 30K

ALSAF.PA long term performance overview.The bars show the price performance of ALSAF.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 -50

The current stock price of ALSAF.PA is 1.09 EUR. In the past month the price decreased by -0.91%. In the past year, price increased by 81.67%.

SAFE ORTHOPAEDICS SA / ALSAF Daily stock chart

ALSAF.PA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to ALSAF.PA. When comparing the yearly performance of all stocks, ALSAF.PA is one of the better performing stocks in the market, outperforming 100% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ALSAF.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALSAF.PA. ALSAF.PA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALSAF.PA Financial Highlights

Over the last trailing twelve months ALSAF.PA reported a non-GAAP Earnings per Share(EPS) of -229246.54. The EPS increased by 99.51% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -22350.4%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%99.87%
Sales Q2Q%-3.07%
EPS 1Y (TTM)99.51%
Revenue 1Y (TTM)-13.24%

ALSAF.PA Forecast & Estimates

For the next year, analysts expect an EPS growth of 14.29% and a revenue growth 11.69% for ALSAF.PA


Analysts
Analysts40
Price TargetN/A
EPS Next Y14.29%
Revenue Next Year11.69%

ALSAF.PA Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

ALSAF.PA Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC 17.2 106.48B
1MDT.MI MEDTRONIC PLC 17.04 105.52B
SHL.DE SIEMENS HEALTHINEERS AG 19.58 52.79B
1SHL.MI SIEMENS HEALTHINEERS AG 19.62 52.88B
PHI1.DE KONINKLIJKE PHILIPS NV 17.39 24.79B
PHIA.AS KONINKLIJKE PHILIPS NV 17.62 25.11B
BIM.PA BIOMERIEUX 27.59 12.61B
OBCK.DE OTTOBOCK SE & CO KGAA 141.91 4.27B
DIA.MI DIASORIN SPA 22.95 4.25B
AFX.DE CARL ZEISS MEDITEC AG - BR 24.62 3.55B
DRW3.DE DRAEGERWERK AG - PREF 12.33 1.49B
ELN.MI EL.EN. SPA 22.75 1.17B

Related stock screener links

About ALSAF.PA

Company Profile

ALSAF logo image Safe SA engages in the development, production and commercialization of spinal surgery products. The company is headquartered in Eragny, Ile-De-France and currently employs 77 full-time employees. The company went IPO on 2015-02-10. The firm focuses on the development and commercialization of products for use in spinal surgery. The company provides a range of implants and ready to use instrument kits. The firm's product portfolio comprises SteriSpine PS, which is the Pedicle Screw System; and SteriSpine LC, which is the Lumbar Cage System that enables safe implant positioning, as well as access, insertion and placement of the implant. The firm's products are equipped with quick change handle, dual trial and impact removal, among others. The firm mainly uses polyarylamid material, which is a polymar with 50% glass fibers.

Company Info

SAFE ORTHOPAEDICS SA

Parc des Bellevues, Batiment le Californie 5, Allee Rosa Luxemburg

Eragny ILE-DE-FRANCE FR

Employees: 138

ALSAF Company Website

ALSAF Investor Relations

Phone: 33134215000

SAFE ORTHOPAEDICS SA / ALSAF.PA FAQ

What does ALSAF do?

Safe SA engages in the development, production and commercialization of spinal surgery products. The company is headquartered in Eragny, Ile-De-France and currently employs 77 full-time employees. The company went IPO on 2015-02-10. The firm focuses on the development and commercialization of products for use in spinal surgery. The company provides a range of implants and ready to use instrument kits. The firm's product portfolio comprises SteriSpine PS, which is the Pedicle Screw System; and SteriSpine LC, which is the Lumbar Cage System that enables safe implant positioning, as well as access, insertion and placement of the implant. The firm's products are equipped with quick change handle, dual trial and impact removal, among others. The firm mainly uses polyarylamid material, which is a polymar with 50% glass fibers.


Can you provide the latest stock price for SAFE ORTHOPAEDICS SA?

The current stock price of ALSAF.PA is 1.09 EUR. The price decreased by -0.91% in the last trading session.


What is the dividend status of SAFE ORTHOPAEDICS SA?

ALSAF.PA does not pay a dividend.


What is the ChartMill rating of SAFE ORTHOPAEDICS SA stock?

ALSAF.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 1 out of 10.